Financial Survey: CorVel (CRVL) & The Competition

CorVel (NASDAQ: CRVL) is one of 46 publicly-traded companies in the “Healthcare Facilities & Services” industry, but how does it weigh in compared to its competitors? We will compare CorVel to similar businesses based on the strength of its profitability, dividends, institutional ownership, analyst recommendations, earnings, risk and valuation.

Profitability

This table compares CorVel and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
CorVel 6.33% 23.74% 13.84%
CorVel Competitors 12.75% 1.56% 1.79%

Analyst Recommendations

This is a summary of recent recommendations and price targets for CorVel and its competitors, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CorVel 0 0 0 0 N/A
CorVel Competitors 249 1495 2015 38 2.49

As a group, “Healthcare Facilities & Services” companies have a potential upside of 2.04%. Given CorVel’s competitors higher possible upside, analysts clearly believe CorVel has less favorable growth aspects than its competitors.

Institutional & Insider Ownership

43.8% of CorVel shares are owned by institutional investors. Comparatively, 70.4% of shares of all “Healthcare Facilities & Services” companies are owned by institutional investors. 51.0% of CorVel shares are owned by company insiders. Comparatively, 15.2% of shares of all “Healthcare Facilities & Services” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Valuation and Earnings

This table compares CorVel and its competitors top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
CorVel $518.69 million $29.47 million 27.64
CorVel Competitors $6.40 billion $199.81 million 482.05

CorVel’s competitors have higher revenue and earnings than CorVel. CorVel is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Volatility and Risk

CorVel has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. Comparatively, CorVel’s competitors have a beta of 0.70, indicating that their average stock price is 30% less volatile than the S&P 500.

Summary

CorVel competitors beat CorVel on 7 of the 10 factors compared.

About CorVel

CorVel Corporation (Corvel) is a provider of workers’ compensation solutions for employers, third party administrators, insurance companies and government agencies. The Company offers its services as a bundled solution, which includes claims management, as a standalone service, or as add-on services to existing customers. The Company offers its services as a bundled solution, which includes claims management, as a standalone service, or as add-on services to existing customers. The Company’s network solutions include bill review, preferred provider organization (PPO) management, professional review, provider reimbursement, pharmacy services, directed care services, medicare solutions and clearinghouse services. The Company’s patient management services include claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, life care planning, disability management, liability claims management and auto claims management.

Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply